<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-588
Date of Submission: 2024-09-17

This report was submitted by a Pharmacist from Arnold Ltd Medical Center concerning patient ANON-PX-1237. The subject is a 64-year-old other with a significant medical history including type 2 diabetes, hypertension. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Amoxicillin (Penicillin antibiotic) administered via the Subcutaneous route at a dosage of 224mg, initiated on 2024-06-24 for Bacterial infection and discontinued on 2024-09-16; Gabapentin (Anticonvulsant) administered via the Topical route at a dosage of 417mg, initiated on 2024-06-24 for Neuropathic pain and discontinued on 2024-09-16.

On approximately 2024-08-14, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Somnolence, Pruritus. The Somnolence was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Pruritus was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 10 was calculated, The assessment concluded the relationship was 'Highly Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Third will would raise like international. Unit training once television. Benefit site every international from.</data>
report_id: ADR-2024-588
report_date: '2024-09-17'
patient_details:
  patient_id: ANON-PX-1237
  gender: Other
  relevant_history:
  - type 2 diabetes
  - hypertension
  age_at_reaction: 64
suspected_drugs:
- drug_name: Amoxicillin
  dosage: 224mg
  route_of_administration: Subcutaneous
  start_date: '2024-06-24'
  indication_for_use: Bacterial infection
  drug_class: Penicillin antibiotic
  end_date: '2024-09-16'
- drug_name: Gabapentin
  dosage: 417mg
  route_of_administration: Topical
  start_date: '2024-06-24'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
  end_date: '2024-09-16'
adverse_reactions:
- symptom_name: Somnolence
  onset_date: '2024-08-14'
  severity: Mild
  outcome: Fatal
  intervention_required: false
- symptom_name: Pruritus
  onset_date: '2024-08-14'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Highly Probable
  dechallenge_rechallenge: Not applicable
  naranjo_score: 10
reporting_facility: Arnold Ltd Medical Center
reporter_type: Pharmacist
notes: Third will would raise like international. Unit training once television. Benefit
  site every international from.
